Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Drapkin

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Oncogenesis|October 25, 2016
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearanceJ N Sheets, M Iwanicki, J F Liu, et al.
Oncogene|November 26, 2009
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesisK Levanon, V Ng, H Y Piao, et al.
Cell|April 13, 2001
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair functionS B Cantor, D W Bell, S Ganesan, et al.
The Journal of Pathology|November 23, 2006
A candidate precursor to serous carcinoma that originates in the distal fallopian tubeY Lee, A Miron, R Drapkin, et al.
Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.
Oncogene|January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumorsS I Labidi-Galy, A Clauss, V Ng, et al.
Oncogenesis|January 31, 2017
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancyB Xu, J Lefringhouse, Z Liu, et al.
Cold Spring Harbor Symposia on Quantitative Biology|June 29, 1999
The RNA polymerase II general transcription factors: past, present, and futureD Reinberg, G Orphanides, R Ebright, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Oncogenesis|October 25, 2016
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearanceJ N Sheets, M Iwanicki, J F Liu, et al.
Oncogene|November 26, 2009
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesisK Levanon, V Ng, H Y Piao, et al.
Cell|April 13, 2001
BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair functionS B Cantor, D W Bell, S Ganesan, et al.
The Journal of Pathology|November 23, 2006
A candidate precursor to serous carcinoma that originates in the distal fallopian tubeY Lee, A Miron, R Drapkin, et al.
Bone Marrow Transplantation|June 1, 1997
Engraftment and outcomes of patients receiving myeloablative therapy followed by autologous peripheral blood stem cells with a low CD34+ cell contentC H Weaver, J Potz, J Redmond, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 1, 1997
Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancerC H Weaver, L S Schwartzberg, R Birch, et al.
Oncogene|January 29, 2014
Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumorsS I Labidi-Galy, A Clauss, V Ng, et al.
Oncogenesis|January 31, 2017
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancyB Xu, J Lefringhouse, Z Liu, et al.
Cold Spring Harbor Symposia on Quantitative Biology|June 29, 1999
The RNA polymerase II general transcription factors: past, present, and futureD Reinberg, G Orphanides, R Ebright, et al.
Pageof 3